Literature DB >> 19084537

The crystal structure of ATP-bound phosphofructokinase from Trypanosoma brucei reveals conformational transitions different from those of other phosphofructokinases.

Iain W McNae1, José Martinez-Oyanedel, Jeffrey W Keillor, Paul A M Michels, Linda A Fothergill-Gilmore, Malcolm D Walkinshaw.   

Abstract

The crystal structure of the ATP-bound form of the tetrameric phosphofructokinase (PFK) from Trypanosoma brucei enables detailed comparisons to be made with the structures of the apoenzyme form of the same enzyme, as well as with those of bacterial ATP-dependent and PP(i)-dependent PFKs. The active site of T. brucei PFK (which is strictly ATP-dependent but belongs to the PP(i)-dependent family by sequence similarities) is a chimera of the two types of PFK. In particular, the active site of T. brucei PFK possesses amino acid residues and structural features characteristic of both types of PFK. Conformational changes upon ATP binding are observed that include the opening of the active site to accommodate the two substrates, MgATP and fructose 6-phosphate, and a dramatic ordering of the C-terminal helices, which act like reaching arms to hold the tetramer together. These conformational transitions are fundamentally different from those of other ATP-dependent PFKs. The substantial differences in structure and mechanism of T. brucei PFK compared with bacterial and mammalian PFKs give optimism for the discovery of species-specific drugs for the treatment of diseases caused by protist parasites of the trypanosomatid family.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19084537     DOI: 10.1016/j.jmb.2008.11.047

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  17 in total

1.  Inorganic polyphosphate interacts with nucleolar and glycosomal proteins in trypanosomatids.

Authors:  Raquel S Negreiros; Noelia Lander; Guozhong Huang; Ciro D Cordeiro; Stephanie A Smith; James H Morrissey; Roberto Docampo
Journal:  Mol Microbiol       Date:  2018-10-18       Impact factor: 3.501

2.  Identification of ML251, a Potent Inhibitor of T. brucei and T. cruzi Phosphofructokinase.

Authors:  Kyle R Brimacombe; Martin J Walsh; Li Liu; Montserrat G Vásquez-Valdivieso; Hugh P Morgan; Iain McNae; Linda A Fothergill-Gilmore; Paul A M Michels; Douglas S Auld; Anton Simeonov; Malcolm D Walkinshaw; Min Shen; Matthew B Boxer
Journal:  ACS Med Chem Lett       Date:  2013-10-30       Impact factor: 4.345

Review 3.  State of the art in African trypanosome drug discovery.

Authors:  Robert T Jacobs; Bakela Nare; Margaret A Phillips
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

4.  Crystallization and preliminary crystallographic analysis of human muscle phosphofructokinase, the main regulator of glycolysis.

Authors:  Marco Kloos; Antje Brüser; Jürgen Kirchberger; Torsten Schöneberg; Norbert Sträter
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-04-25       Impact factor: 1.056

5.  Plasmodium vivax tryptophan-rich antigen PvTRAg33.5 contains alpha helical structure and multidomain architecture.

Authors:  Hema Bora; Sheena Garg; Priyankar Sen; Deepak Kumar; Punit Kaur; Rizwan Hasan Khan; Yagya D Sharma
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

6.  Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations.

Authors:  Bradley A Webb; Farhad Forouhar; Fu-En Szu; Jayaraman Seetharaman; Liang Tong; Diane L Barber
Journal:  Nature       Date:  2015-05-18       Impact factor: 49.962

7.  Evaluation of Antigens for Development of a Serological Test for Human African Trypanosomiasis.

Authors:  Sylvain Biéler; Harald Waltenberger; Michael P Barrett; Richard McCulloch; Jeremy C Mottram; Mark Carrington; Wilhelm Schwaeble; James McKerrow; Margaret A Phillips; Paul A Michels; Philippe Büscher; Jean-Charles Sanchez; Richard Bishop; Derrick R Robinson; James Bangs; Michael Ferguson; Barbara Nerima; Audrey Albertini; Gerd Michel; Magdalena Radwandska; Joseph Mathu Ndung'u
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 8.  The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.

Authors:  Ifedayo Victor Ogungbe; William N Setzer
Journal:  Molecules       Date:  2016-10-19       Impact factor: 4.411

9.  Identification of a pyrophosphate-dependent kinase and its donor selectivity determinants.

Authors:  Ryuhei Nagata; Masahiro Fujihashi; Takaaki Sato; Haruyuki Atomi; Kunio Miki
Journal:  Nat Commun       Date:  2018-05-02       Impact factor: 14.919

10.  Kinetic and structural studies of Trypanosoma and Leishmania phosphofructokinases show evolutionary divergence and identify AMP as a switch regulating glycolysis versus gluconeogenesis.

Authors:  Peter M Fernandes; James Kinkead; Iain W McNae; Monserrat Vásquez-Valdivieso; Martin A Wear; Paul A M Michels; Malcolm D Walkinshaw
Journal:  FEBS J       Date:  2020-01-08       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.